In the second in a series of three podcasts, C+D speaks with Dr Elizabeth Angier, a portfolio GP with an interest in allergy.
Dr Angier works across hospitals, the community and commissioning. She is chair of the European Academy of Allergy and Clinical Immunology (EAACI) working group in primary care and was previously chair of the primary care group at the British Society of Allergy and Clinical Immunology (BSACI).
You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching “Chemist+Druggist podcast” on your preferred Android podcast app.
In this podcast, Dr Angier discusses the challenges faced by allergy patients during the pandemic, such as how they may face social stigma from others who confuse their allergy symptoms with symptoms of COVID-19.
“Patients with allergy [per se] are not considered as vulnerable”, says Dr Angier, however “those with uncontrolled symptoms may be at greater risk of [contracting] COVID-19”.
Dr Angier emphasises the importance of keeping allergy symptoms under control to prevent the risk of contracting COVID-19. “It is important for allergy patients to continue medications as normal,” she says.
Listen to the first podcast in this series on the differential diagnosis between allergy and COVID-19. In this podcast, Dr Angier discusses how symptoms in allergy and COVID-19 infection may overlap and how the two conditions can be confused.
This podcast has been developed in partnership with Piri – from the makers of Piriton.
For product information click here.